Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016 Jul 27;70(4):299-302.
doi: 10.5455/medarh.2016.70.299-302.

Treatment of Hypertension with Combination of Lisinopril/Hydrochlorothiazide

Aziz Sukalo  1 , Dervis Deljo  1 , Amina Krupalija  2 , Nerma Zjajo  2 , Sabina Kos  2 , Amela Curic  2 , Goran Divkovic  2 , Sabina Hubjar  2 , Mina Smailagic  2 , Edina Hodzic  3 , Danijela Marjanovic  3 , Senad Medjedovic  4
Affiliations
Randomized Controlled Trial

Treatment of Hypertension with Combination of Lisinopril/Hydrochlorothiazide

Aziz Sukalo et al. Med Arch. .

Abstract

Introduction: Paper is written on the basis of data collected in collaboration with family doctors in several cities in Bosnia and Herzegovina.

Material and methods: In this retrospective, randomized study was carried out processing of data collected by special design questionnaire from the field through studies and analyzes carried out in 5 health care institutions in the territory of Bosnia and Herzegovina. The study included 270 patients who underwent three consecutive medical examinations.

Results: Total reduction in blood pressure in average was 32.8 mmHg for systolic and 17.1 mmHg for diastolic, which is consistent with previously published results. Lisinopril/Hydrochlorothiazide is therefore a valuable therapy in the field of internal medicine. Study of this medication confirmed its efficacy in the treatment of hypertension.

Conclusion: Control of high blood pressure in our patients according to data was very low, so it is necessary to intensify measures of prevention and treatment.

Keywords: Lisinopril/hydrochlorothiazide; hypertension; treatment.

PubMed Disclaimer

Conflict of interest statement

• Conflict of interest: none declared.

Figures

Figure 1
Figure 1
Review of systolic pressure over three measurements
Figure 2
Figure 2
Review of diastolic pressure through three measurements
Figure 3
Figure 3
Review of heart rate through three measurements
Figure 4
Figure 4
The types of side eff ects (χ2=3.155; p=0.207)
Figure 5
Figure 5
Treatment effi cacy (χ2=0.560; p=0.906)
See this image and copyright information in PMC

References

    1. Antihypertensives effectiveness of low-dose Lisinopril-hydrochlorothiazide combination. A large multicenter study. Lisinopril-Hydrochlorothiazide Group., Chrysant SG. Arch-Intern-Med. 1994 Apr 11;154(7):737–43. - PubMed
    1. Angiotensin converting enzyme inhibitors enhance the antihypertensives efficacy of diuretics and blunt or prevent adverse metabolic effects. Weinberger MH. 1989. J. Cardiovascular. Pharmacol. 13:S1–S4. - PubMed
    1. Patlak M. “From viper's venom to drug design: treating hypertension”. FASEB J. 2004 Mar;18(3):421. - PubMed
    1. Katzung Bertram. Basic and Clinical Pharmacology. Vol. 175. New York City, New York: McGraw Hill; 2012. pp. 184–185.
    1. Drug Information for the Health Care Professional (USP DI) (2001): Lisinopril. (21th ed) I:171–179.

Publication types

LinkOut - more resources